Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Dema, Barbara ^a   Pellefigues, Christophe ^b   Hasni, Sarfaraz ^a   Gault, Nathalie ^c   Jiang, Chao ^a   Ricks, Tiffany K ^a   Bonelli, Michael M ^a   Scheffel, Jörg ^a   Sacre, Karim ^b,c   Jablonski, Mathieu ^c   Gobert, Delphine ^c   Papo, Thomas ^b,c   Daugas, Eric ^b,c   Illei, Gabor ^d   Charles, Nicolas ^b   Rivera, Juan ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b INSERM   (France)

^c BICHAT HOSPITAL   (France)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; LA ANTIBODY; PROTEIN SM;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL INDICATOR; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PREDICTIVE VALUE; PREVALENCE; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; COHORT STUDIES; DNA; FEMALE; FRANCE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LUPUS NEPHRITIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84896518122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090424     Document Type: Article

References (35)

1. Frieri M (2013) Mechanisms of disease for the clinician: systemic lupus erythematosus. Ann Allergy Asthma Immunol 110: 228-232.
2. Sawalha AH, Harley JB (2004) Antinuclear autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 16: 534-540. (Pubitemid 39128320)
3. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533. (Pubitemid 37255038)
4. Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358: 929-939. (Pubitemid 351397092)
5. Schroeder K, Herrmann M, Winkler TH (2012) The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity 46: 121-127.
6. Kalaaji M, Fenton KA, Mortensen ES, Olsen R, Sturfelt G, et al. (2007) Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 71: 664-672. (Pubitemid 46494570)
7. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
8. Capron A, Dessaint JP (1977) IgE and cells in protective immunity. Pathol Biol (Paris) 25: 287-290. (Pubitemid 8129767)
9. Blank U, Rivera J (2004) The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25: 266-273. (Pubitemid 38501673)
10. Permin H, Wiik A (1978) The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus. Acta Pathol Microbiol Scand C 86C: 245-249. (Pubitemid 9043749)
11. Atta AM, Santiago MB, Guerra FG, Pereira MM, Sousa Atta ML (2010) Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus. Int Arch Allergy Immunol 152: 401-406.
12. Charles N, Hardwick D, Daugas E, Illei GG, Rivera J (2010) Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 16: 701-707.
13. Bosch X, Lozano F, Cervera R, Ramos-Casals M, Min B (2011) Basophils, IgE, and autoantibody-mediated kidney disease. J Immunol 186: 6083-6090.
14. Rodriguez Gomez M, Talke Y, Goebel N, Hermann F, Reich B, et al. (2010) Basophils support the survival of plasma cells in mice. J Immunol 185: 7180-7185.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277. (Pubitemid 13221242)
16. Kallenberg CG, Stegeman CA, Bootsma H, Bijl M, Limburg PC (2006) Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful? Lupus 15: 397-402. (Pubitemid 44147083)
17. Livingston B, Bonner A, Pope J (2012) Differences in autoantibody profiles and disease activity and damage scores between childhood-and adult-onset systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 42: 271-280.
18. Sweiss NJ, Bo R, Kapadia R, Manst D, Mahmood F, et al. (2010) IgA antibeta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus. PLoS One 5: e12280.
19. Mehrani T, Petri M (2011) Association of IgA Anti-beta2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus. J Rheumatol 38: 64-68.
20. Miltenburg AM, Roos A, Slegtenhorst L, Daha MR, Breedveld FC (1993) IgA anti-dsDNA antibodies in systemic lupus erythematosus: occurrence, incidence and association with clinical and laboratory variables of disease activity. J Rheumatol 20: 53-58. (Pubitemid 23049182)
21. Witte T, Hartung K, Matthias T, Sachse C, Fricke M, et al. (1998) Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group. Rheumatol Int 18: 63-69. (Pubitemid 28432836)
22. Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, et al. (2013) Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG antidsDNA help to identify glomerulonephritis and active disease. PLoS One 8: e71458.
23. Latiff AH, Kerr MA (2007) The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem 44: 131-139. (Pubitemid 46525008)
24. Mantovani AP, Monclaro MP, Skare TL (2010) Prevalence of IgA deficiency in adult systemic lupus erythematosus and the study of the association with its clinical and autoantibody profiles. Rev Bras Rheumatol 50: 273-282.
25. Witte T, Hartung K, Sachse C, Matthias T, Fricke M, et al. (1998) IgM antidsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group. Rheumatol Int 18: 85-91. (Pubitemid 28505328)
26. Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, et al. (2005) Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum 52: 3629-3638. (Pubitemid 41612234)
27. Forger F, Matthias T, Oppermann M, Becker H, Helmke K (2004) Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 13: 36-44. (Pubitemid 38129349)
28. Kenderov A, Minkova V, Mihailova D, Giltiay N, Kyurkchiev S, et al. (2002) Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies. Clin Exp Immunol 129: 169-176.
29. Bijl M, Dijstelbloem HM, Oost WW, Bootsma H, Derksen RH, et al. (2002) IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus. Rheumatology (Oxford) 41: 62-67. (Pubitemid 34537922)
30. Madaio MP, Carlson J, Cataldo J, Ucci A, Migliorini P, et al. (1987) Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol 138: 2883-2889. (Pubitemid 17072763)
31. Pankewycz OG, Migliorini P, Madaio MP (1987) Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol 139: 3287-3294. (Pubitemid 18021979)
32. Charles N, Rivera J (2011) Basophils and autoreactive IgE in the pathogenesis of systemic lupus erythematosus. Current allergy and asthma reports 11: 378-387.
33. Tuma SN, Llach F, Sostrin S, Dubois EL, Massry SG (1981) Glomerular IgE deposits in patients with lupus nephritis. Am J Nephrol 1: 31-36. (Pubitemid 12227792)
34. Altin J, Shen C, Liston A (2010) Understanding the genetic regulation of IgE production. Blood Rev 24: 163-169.
35. Pate MB, Smith JK, Chi DS, Krishnaswamy G (2010) Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective. Clin Mol Allergy 8: 3. Diseases